Background
==========

The diuretic effects of atrial natriuretic peptide (ANP-99-126) are reduced in patients with advanced cirrhosis of the liver and severe myocardial dysfunction. These patients also often display an increased acitivity of the renin-angiotensin-aldosterone system (RAAS) resulting in high plasma concentrations of aldosterone (ALD) and angiotensin II (AII).

Objective
=========

To study the effects of ANP in isolated perfused rat kidneys after pretreatment with AII or ALD to determine which hormone causes ANP unresponsiveness in this setting.

Materials and methods
=====================

Three groups of kidneys were perfused for 3 h with a constant perfusion pressure of 100 mmHg.: a control group (*n* = 5), a AII/ANP group (*n* = 6; 0.1 nmol/l AII in the second hour; 3.25 nmol/l hANP in the third hour) and an ALD/ANP group (*n* = 4; 27.7 nmol/l ALD in the second hour; 3.25 nmol/l hANP in the third hour). We determined urine flow (VU), urinary excretion of sodium (V~Na~U) and potassium (V~k~U), inulin-clearance (GFR) and renal vascular resistance RVR.

Results
=======

*AII/ANP group*: treatment with AII decreased VU, V~Na~U, V~k~U and GFR and increased RVR. ANP restored renal function to control levels (V~Na~U, V~k~U, GFR) or above (VU, RVR). *ALD/ANP group*: treatment with ALD induced an increase of V~k~U. Subsequent treatment with ANP further increased V~k~U and slightly decreased RVR. No effects on GFR, VU or V~Na~U were observed.

Conclusion
==========

Our findings suggest that blunted ANP effects during increased RAAS-activity are mainly determined by ALD. Interestingly, this is not only due to a blunted increase of sodium excretion (tubular mechanism) but also due to a blunted increase of glomerular filtration rate (altered glomerular vascular reactivity).
